Financial Performance - Operating revenue for the period reached CNY 96,749,829.85, reflecting a 16.35% increase year-on-year[5] - Net profit attributable to shareholders rose by 30.48% to CNY 9,105,540.94 compared to the same period last year[5] - Basic earnings per share increased by 28.57% to CNY 0.09[5] - Total operating revenue for Q1 2021 reached CNY 96,749,829.85, an increase of 16.1% compared to CNY 83,154,948.90 in Q1 2020[30] - The company's net profit for Q1 2021 was not explicitly stated, but the increase in revenue and costs suggests a focus on maintaining profitability amidst growth[30] - Net profit for Q1 2021 reached CNY 8,376,450.68, representing a growth of 11.9% from CNY 7,484,029.00 in the same period last year[34] - The total comprehensive income for Q1 2021 was CNY 8,376,450.68, an increase of 11.9% from CNY 7,484,029.00 in Q1 2020[34] - Operating profit for Q1 2021 was CNY 10,580,400.70, up from CNY 9,502,858.23 in Q1 2020, reflecting a growth of 11.3%[34] Asset and Liability Management - Total assets increased by 28.49% to CNY 1,684,747,345.35 compared to the end of the previous year[5] - The company's total assets reached CNY 1,500,574,724.11, up from CNY 1,118,555,786.84, indicating strong asset growth[29] - The total liabilities rose to CNY 604,532,640.22 from CNY 238,273,951.19, showing a substantial increase in financial obligations[22] - Long-term borrowings surged by 1537.70% to ¥457,493,136.09 from ¥27,935,106.38, reflecting significant new bank loans[13] - The long-term borrowings increased to CNY 457,493,136.09 from CNY 27,935,106.38, suggesting a strategic move to leverage debt for expansion[22] Cash Flow Analysis - The net cash flow from operating activities improved by 52.51%, amounting to CNY -18,162,009.79[5] - Cash and cash equivalents increased by 127.60% to ¥443,615,786.08 from ¥194,910,699.25 due to increased bank borrowings[13] - Cash inflow from operating activities was CNY 112,965,497.94, compared to CNY 97,793,817.32 in Q1 2020, marking a 15.4% increase[38] - The net cash flow from operating activities for Q1 2021 was -30,763,404.07 RMB, an improvement from -36,506,619.27 RMB in Q1 2020[41] - The net cash flow from investing activities decreased significantly by 20738.05% to -¥150,943,959.82 from ¥731,386.91, primarily due to increased investments in financial products and construction projects[15] - The net cash flow from financing activities increased by 4909.97% to ¥421,279,459.69 from ¥8,408,824.22, driven by a substantial rise in bank borrowings[15] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,468[10] - The largest shareholder, Shaanxi Kanghui Holdings Co., Ltd., holds 39.65% of the shares[10] Operational Insights - The company has not disclosed any new product developments or market expansion strategies in this report[5] - The company plans to continue expanding its market presence and invest in new product development to drive future growth[34] - Sales expenses increased by 45.03% to ¥28,811,884.11 from ¥19,866,286.80 due to higher marketing costs[15] - Financial expenses rose by 151.50% to ¥331,775.56 from -¥644,239.35, mainly due to increased interest expenses on bank loans[15] - Research and development expenses for Q1 2021 were CNY 1,285,599.31, a decrease of 17.7% from CNY 1,562,801.66 in Q1 2020[34] Receivables and Inventory - Accounts receivable decreased by 43.43% to ¥13,025,701.39 from ¥23,027,209.89 primarily due to the maturity of notes payable[13] - Other receivables increased by 196.80% to ¥20,716,557.00 from ¥6,979,897.26, mainly due to an increase in daily operational transactions[13] - Inventory levels rose to CNY 89,798,145.58 from CNY 72,884,024.27, reflecting increased stock to support anticipated sales growth[25] - The company reported a significant increase in other receivables, which rose to CNY 77,052,576.47 from CNY 44,561,150.34, indicating potential growth in customer credit[25] - Deferred income increased to CNY 16,899,500.23 from CNY 11,953,000.22, suggesting a rise in advance payments from customers[29]
康惠制药(603139) - 2021 Q1 - 季度财报